ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $688,432,000 | +82.9% | 4,476,100 | +49.2% | 10.82% | +65.1% |
| Q2 2021 | $376,470,000 | -7.5% | 3,000,000 | 0.0% | 6.55% | -6.8% |
| Q1 2021 | $406,830,000 | +105.2% | 3,000,000 | +93.5% | 7.03% | +105.7% |
| Q4 2020 | $198,307,000 | +30.5% | 1,550,000 | +14.8% | 3.42% | +58.2% |
| Q3 2020 | $151,916,000 | +53.3% | 1,350,000 | +29.8% | 2.16% | +10.2% |
| Q2 2020 | $99,081,000 | +28.2% | 1,040,000 | +20.9% | 1.96% | -24.9% |
| Q1 2020 | $77,288,000 | – | 860,000 | – | 2.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |